Radhakrishnan A, Li Y, Furgal AKC, Hamilton AS, Ward KC, Jagsi R, Katz SJ, Hawley ST, Wallner LP. JCO. Published online March 11, 2019 [ePub ahead of print].
Wallner LP, Li Y, McLeod MC, Gargaro J, Kurian AW, Jagsi R, Radhakrishnan A, Hamilton AS, Ward KC, Hawley ST, Katz SJ. Cancer. Published online February 1, 2019 [Epub ahead of print].
Association of Germline Genetic Test Type and Results With Patient Cancer Worry After Diagnosis of Breast Cancer
Physician Attitudes About Cost Consciousness for Breast Cancer Treatment: Differences by Cancer Sub-Specialty
Surgeon Attitudes Toward the Omission of Axillary Dissection in Early Breast Cancer
Knowledge about and patterns of genetic testing in newly diagnosed breast cancer patients participating in the iCanDecide Trial
Association of Attending Surgeon With Variation in the Receipt of Genetic Testing After Diagnosis of Breast Cancer
Unmet Need for Clinician Engagement Regarding Financial Toxicity After Diagnosis of Breast Cancer
Patient Views and Correlates of Radiotherapy Omission in a Population-Based Sample of Older Women with Favorable Prognosis Breast Cancer
Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer
Recent Trends in Chemotherapy Use and Oncologists’ Treatment Recommendations for Early-Stage Breast Cancer
Gaps in Receipt of Clinically Indicated Genetic Counseling After Diagnosis of Breast Cancer
Patient Experiences and Clinician Views on the Role of Radiation Therapy for Ductal Carcinoma In Situ
Reducing Overtreatment of Cancer With Precision Medicine: Just What the Doctor Ordered
Improving Breast Cancer Surgical Treatment Decision Making: The iCanDecide Randomized Clinical Trial
Surgeon Influence on Variation in Receipt of Contralateral Prophylactic Mastectomy For Women With Breast Cancer
What Factors Influence Women’s Perceptions of their Systemic Recurrence Risk after Breast Cancer Treatment?
Treatment decisions and employment of breast cancer patients: Results of a population-based survey
Trends in Reoperation After Initial Lumpectomy for Breast Cancer: Addressing Overtreatment in Surgical Management
Patient Preferences for Primary Care Provider Roles in Breast Cancer Survivorship Care
The association between patient attitudes and values and the strength of consideration for contralateral prophylactic mastectomy in a population-based sample of breast cancer patients
Oncologists’ influence on receipt of adjuvant chemotherapy: does it matter whom you see for treatment of curable breast cancer?
Decision-support networks of women newly diagnosed with breast cancer
Treatment experiences of Latinas after diagnosis of breast cancer
Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer
Patient Reactions to Surgeon Recommendations About Contralateral Prophylactic Mastectomy for Treatment of Breast Cancer
Surgeon Attitudes and Use of MRI in Patients Newly Diagnosed with Breast Cancer
Treatment-associated toxicities reported by patients with early-stage invasive breast cancer
Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer
Second Opinions From Medical Oncologists for Early-Stage Breast Cancer: Prevalence, Correlates, and Consequences
Study protocol: A randomized controlled trial of a comprehensive breast cancer treatment patient decision tool (iCanDecide)
Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer
The impact of doctor-patient communication on patients’ perceptions of their risk of breast cancer recurrence
Recurrence risk perception and quality of life following treatment of breast cancer
The influence of 21-gene recurrence score assay on chemotherapy use in a population-based sample of breast cancer patients
Chemotherapy Decisions and Patient Experience With the Recurrence Score Assay for Early-Stage Breast Cancer
Discordance between original and central laboratories in ER and HER2 results in a diverse, population-based sample
Does physician communication style impact patient report of decision quality for breast cancer treatment?
Use of Online Communication by Patients With Newly Diagnosed Breast Cancer During the Treatment Decision Process
Involvement of Primary Care Physicians in the Decision Making and Care of Patients With Breast Cancer
Evaluating a Decision Aid for Improving Decision Making in Patients with Early-stage Breast Cancer
Prescription drug coverage: implications for hormonal therapy adherence in women diagnosed with breast cancer
Addressing Overtreatment in DCIS: What Should Physicians Do Now?
Treatment Decision Making and Genetic Testing for Breast Cancer: Mainstreaming Mutations
Cancer Care Delivery Research and the National Cancer Institute SEER Program Challenges and Opportunities.
Concerns About Cancer Risk and Experiences With Genetic Testing in a Diverse Population of Patients With Breast Cancer.
Patient-Reported Quality of Life and Satisfaction with Cosmetic Outcomes After Breast Conservation and Mastectomy with and without Reconstruction: Results of a Survey of Breast Cancer Survivors.
Development and psychometric properties of a brief measure of subjective decision quality for breast cancer treatment.
Access to breast reconstruction after mastectomy and patient perspectives on reconstruction decision making.
Impact of adjuvant chemotherapy on long-term employment of survivors of early-stage breast cancer.
Social and clinical determinants of contralateral prophylactic mastectomy.
Providers of follow-up care in a population-based sample of breast care survivors.
Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries.
Treatment decision aids are unlikely to cut healthcare costs.
The value of sharing treatment decision-making with patients: are we expecting too much?
Addressing Over-Treatment in Breast Cancer: The Doctors’ Dilemma.
Contralateral Prophylactic Mastectomy for Breast Cancer: Addressing Peace of Mind.
Adjuvant endocrine therapy initiation and persistence in a diverse sample of patients with breast cancer.
The Challenge of Individualizing Treatments for Patients with Breast Cancer.
Dissemination of Quality Care Research Findings to Breast Oncology Surgeons
Coordinating Cancer Care: Patient and Practice Management Processes Among Surgeons Who Treat Breast Cancer.
Surgeon recommendations and receipt of mastectomy for treatment of breast cancer.
Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients.
Racial/ethnic differences in adequacy of information and support for women with breast cancer.
Symptom Experience and Quality of Life of Women Following Breast Cancer Treatment.
Patient satisfaction with the treatment of breast cancer: does surgeon specialization matter?